Howard Chang, PhD
Vice President, Operations
Howard joined BridgeBio Pharma in November 2019, leading operations and managing collaborations for its oncology affiliates from discovery to the clinic, and is now Vice President of Operations at BBOT. Prior to joining BridgeBio, Howard was a Director at Amgen Inc., filling commercial roles across multiple therapeutic areas. He was also a management consultant for biopharma companies, and a part of the out-licensing team at UCLA’s technology transfer office.
Howard earned his PhD in Biochemistry and Molecular Biology from David Eisenberg’s lab at UCLA, and a BS in Biochemistry and Cell Biology from UCSD.